Literature DB >> 35943518

Clinical and imaging predictors of the natural course of bland portal vein thrombus in cirrhotic patients.

Meghana Konanur1, Celia Reynolds1, Erin Shropshire1, Reginald Lerebours2, Benjamin Wildman-Tobriner1, Brian Allen1, Tracy Jaffe1, Alaattin Erkanli2, Mustafa Bashir3,4.   

Abstract

BACKGROUND: Portal vein thrombus (PVT) in cirrhotic patients is associated with worsening portal hypertension, leads to increased complexity of necessary interventions such as transjugular liver portosystemic shunt or liver transplantation, and is associated with worse outcomes after liver transplantation. Additionally, there are no established consensus guidelines for management of bland PVT in cirrhotic patients, which currently exists on a spectrum and is patient and provider dependent.
PURPOSE: The aim of this study was to determine whether there are associations between key clinical and imaging variables and bland PVT burden over time.
MATERIAL AND METHODS: This exploratory, retrospective, single-center study included patients who underwent two or more multiphase CT or MRI examinations between 1/1/2013 and 12/31/2019 and had a diagnosis of PVT. Three readers independently evaluated all index and follow-up examinations for PVT burden using a proposed 8-point scale and the established Yerdel score. Key clinical factors were collected from the electronic medical record. The PVT burden over time and the association of this burden with key clinical and imaging variables were assessed using logistic regression models.
RESULTS: 138 patients with cirrhosis and bland PVT were included in the analyses. Median age was 60 years (interquartile range 55-67; 90 men) and median follow-up time was 19.6 months. At baseline, the mean score was 2.31 (± 1.44) and at the final follow-up examination, the mean score was 2.52 (± 1.99). Baseline occlusion level was the only statistically significant association with worsening PVT burden in all four vascular territories (p-value < 0.0001). Anticoagulation status did not have a statistically significant association with change in thrombus burden in any vascular territory or cumulative thrombus burden across all territories (p-value 0.11-0.43).
CONCLUSION: In conclusion, our study shows that in cirrhotic patients with bland PVT, the thrombus burden did not change significantly over time and baseline thrombus burden is the only clinical factor significantly associated with increasing burden over time.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CT scan; Cirrhosis; MRI scan; Portal hypertension; Thrombus

Mesh:

Substances:

Year:  2022        PMID: 35943518     DOI: 10.1007/s00261-022-03626-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  18 in total

1.  Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.

Authors:  M A Yerdel; B Gunson; D Mirza; K Karayalçin; S Olliff; J Buckels; D Mayer; P McMaster; J Pirenne
Journal:  Transplantation       Date:  2000-05-15       Impact factor: 4.939

Review 2.  Nontumoral portal vein thrombosis in patients awaiting liver transplantation.

Authors:  Hui Chen; Fanny Turon; Virginia Hernández-Gea; Josep Fuster; Angeles Garcia-Criado; Marta Barrufet; Anna Darnell; Constantino Fondevila; Juan Carlos Garcia-Valdecasas; Juan Carlos Garcia-Pagán
Journal:  Liver Transpl       Date:  2016-03       Impact factor: 5.799

3.  Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.

Authors:  Lucio Amitrano; Maria Anna Guardascione; Antonella Menchise; Rossana Martino; Mariano Scaglione; Sabrina Giovine; Luigia Romano; Antonio Balzano
Journal:  J Clin Gastroenterol       Date:  2010-07       Impact factor: 3.062

Review 4.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

5.  Reply: To PMID 22819864.

Authors:  Erica Villa; Calogero Cammà; Dominique Valla
Journal:  Gastroenterology       Date:  2012-12-21       Impact factor: 22.682

6.  Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis.

Authors:  J Lakhoo; R C Gaba
Journal:  Diagn Interv Imaging       Date:  2016-07-29       Impact factor: 4.026

7.  Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.

Authors:  C Francoz; J Belghiti; V Vilgrain; D Sommacale; V Paradis; B Condat; M H Denninger; A Sauvanet; D Valla; F Durand
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 8.  Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.

Authors:  Lorenzo Loffredo; Daniele Pastori; Alessio Farcomeni; Francesco Violi
Journal:  Gastroenterology       Date:  2017-05-04       Impact factor: 22.682

9.  Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.

Authors:  Marwan Ghabril; Saurabh Agarwal; Marco Lacerda; Naga Chalasani; Paul Kwo; A Joseph Tector
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

Review 10.  Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Patrick G Northup; Juan Carlos Garcia-Pagan; Guadalupe Garcia-Tsao; Nicolas M Intagliata; Riccardo A Superina; Lara N Roberts; Ton Lisman; Dominique C Valla
Journal:  Hepatology       Date:  2021-01-20       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.